Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling
Pillar 4: GLP-1 receptor agonists and dual agonists GLP-1-based therapies (such as semaglutide and tirzepatide) are a legitimate pillar for insulin resistance management when obesity and/or appetite dysregulation are part of the picture
Environmental Science & Technology, 43(16): 62566261 Kravchenko I, Rayko M, Tikhonova E, Konopkin A, Abakumov E, Lapidus A (2022)
Aquat Toxicol 20:301307 Pinho GLL, Moura de Rosa C, Maciel FE, Bianchini A, Yunes JS, Pronca LAO, Monserrat JM (2005) Antioxidant responses and oxidative stress after microcystin exposure in the hepatopancreas of an estuarine crab species